| Field Name |
Data Description |
| Test Name |
Ethosuximide Level |
| Code |
Ethosuximide Level Peak. |
|
CPT Code |
80168 |
| Last Modified |
4/23/2018 3:54:00 PM |
| Test Name |
Ethosux. |
| Synonyms |
Zarontin, TDM, peak |
| Patient Preparation |
State other drugs taken by patient. |
| Spec. Requirements |
Blood |
| Tube |
Red (No Gel), Dark Green (Heparinized non gel tube), Lavender (EDTA), |
| Collection Volume |
4.0 mL Red or Drk.Green, 2.0 mL Lavender |
| Storage |
Ambient, Refrigerate, or Freeze 14 days |
| Routine TAT |
|
| STAT TAT |
N/A |
| Days Test Performed |
|
| Performed by BHS |
None |
| See Availability |
|
| Reference Lab |
LabCorp of America |
| Reference Lab Code |
007443 Ethosuximide (Zarontin), Serum |
| Clinical Use |
Ethosuximide is an anticonvulsant used to treat seizures. Ethosuximide levels are monitored to assure adequate therapeutic levels are achieved and to avoid toxicity. |
| Reference Range |
|
| Critical Value |
|
|
Component |
|
|
Reference Range |
|
|
Critical Value |
|
 |
|
| Testing Sample Type |
Serum or Plasma |
| Min Lab Testing Volume |
0.6 mL |
| Special Handling |
Collection:Transfer separated serum or plasma to a plastic transport tube. Oral: peak: two to four hours after dose; trough: immediately prior to next dose. Peak or trough levels may be used to monitor therapy because blood levels are fairly constant. |
| Lab Notes |
|
| Methodology |
IA - Immunoassay |
| Limitations |
Causes for Rejection: Gel-barrier tube; hemolysis; lipemia; gross bacterial contamination |
